1Idrissa, H., *2Abdoulaye, O., 3Yacouba, A., 3Alhousseini Maiga, D., 1Moumouni Sambo, H., 4Doutchi, M., 5Chaibou, S., 6Sani, O., 3Mamadou, S., and 7Sangare, L.
1Direction des Laboratoires de santé (DLS), Ministère de la santé publique, Niger
2Faculté des Sciences de la Santé, Université Dan Dicko Dankoulodo, Maradi, BP 465, Niger
3Faculté des Sciences de la Santé, Université Abdou Moumouni, Niamey, Niger
4Faculté des Sciences de la Santé, Université de Zinder, Niger
5Hôpital Général de Référence de Niamey, Niger
6Centre de Recherche Médicale et Sanitaire, Niger
7Unité de Formation et de Recherhe en Sciences de la Santé (UFR/SDS), Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
*Correspondence to: ousmaneabdoulaye2010@yahoo.com; +227 96354580
Abstract:
Background: Risk assessment is the means of identifying and evaluating potential errors or problems that may occur in testing process. The aim of this study was to perform risk assessment of antimicrobial susceptibility testing (AST) process in clinical microbiology laboratories of Niamey, Niger Republic.
Methodology: We conducted a descriptive cross-sectional study from October 1 to December 31, 2019, to evaluate AST performance in seven clinical microbiology laboratories at Niamey, the capital city of Niger republic. The evaluation focused on the determination of the criticality index (CI) of each critical point (frequency of occurrence of anomalies, severity of the process anomaly, and detectability of the anomaly during the process) in the AST process and the performance of the AST through an observation sheet using two reference strains; Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213. Continue reading “Evaluation of the antimicrobial susceptibility testing process in clinical microbiology laboratories at Niamey, Niger”